|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abraham C and Cho JH: Inflammatory bowel
disease. N Engl J Med. 361:2066–2078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaplan GG and Ng SC: Globalisation of
inflammatory bowel disease: Perspectives from the evolution of
inflammatory bowel disease in the UK and China. Lancet
Gastroenterol Hepatol. 1:307–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fumery M, Dulai PS, Gupta S, Prokop LJ,
Ramamoorthy S, Sandborn WJ and Singh S: Incidence, risk factors,
and outcomes of colorectal cancer in patients with ulcerative
colitis with low-grade dysplasia: A systematic review and
meta-analysis. Clin Gastroenterol Hepatol. 15:665–674.e5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rogler G: Chronic ulcerative colitis and
colorectal cancer. Cancer Lett. 345:235–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eaden JA, Abrams KR and Mayberry JF: The
risk of colorectal cancer in ulcerative colitis: A meta-analysis.
Gut. 48:526–535. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herrinton LJ, Liu L, Levin TR, Allison JE,
Lewis JD and Velayos F: Incidence and mortality of colorectal
adenocarcinoma in persons with inflammatory bowel disease from 1998
to 2010. Gastroenterology. 143:382–389. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sebastian S, Hernández V, Myrelid P, Kariv
R, Tsianos E, Toruner M, Marti-Gallostra M, Spinelli A, van der
Meulen-de Jong AE, Yuksel ES, et al: Colorectal cancer in
inflammatory bowel disease: Results of the 3rd ECCO pathogenesis
scientific workshop (I). J Crohns Colitis. 8:5–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yashiro M: Ulcerative colitis-associated
colorectal cancer. World J Gastroenterol. 20:16389–16397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ording AG, Horváth-Puhó E, Erichsen R,
Long MD, Baron JA, Lash TL and Sørensen HT: Five-year mortality in
colorectal cancer patients with ulcerative colitis or Crohn's
disease: A nationwide population-based cohort study. Inflamm Bowel
Dis. 19:800–805. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Itzkowitz SH and Yio X: Inflammation and
cancer IV. Colorectal cancer in inflammatory bowel disease: The
role of inflammation. Am J Physiol Gastrointest Liver Physiol.
287:G7–G17. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo C and Zhang H: The role of
proinflammatory pathways in the pathogenesis of colitis-associated
colorectal cancer. Mediators Inflamm. 2017:51260482017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kinugasa T and Akagi Y: Status of
colitis-associated cancer in ulcerative colitis. World J
Gastrointest Oncol. 8:351–357. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ambros V: MicroRNAs and developmental
timing. Curr Opin Genet Dev. 21:511–517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saraggi D, Fassan M, Mescoli C, Scarpa M,
Valeri N, Michielan A, D'Incá R and Rugge M: The molecular
landscape of colitis-associated carcinogenesis. Dig Liver Dis.
49:326–330. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Romano M, De Francesco F, Zarantonello L,
Ruffolo C, Ferraro GA, Zanus G, Giordano A, Bassi N and Cillo U:
From inflammation to cancer in inflammatory bowel disease:
Molecular perspectives. Anticancer Res. 36:1447–1460.
2016.PubMed/NCBI
|
|
18
|
Schlemper RJ, Riddell RH, Kato Y, Borchard
F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Fléjou JF,
Geboes K, et al: The Vienna classification of gastrointestinal
epithelial neoplasia. Gut. 47:251–255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ungaro R, Mehandru S, Allen PB,
Peyrin-Biroulet L and Colombel JF: Ulcerative colitis. Lancet.
389:1756–1770. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Torres J, Mehandru S, Colombel JF and
Peyrin-Biroulet L: Crohn's disease. Lancet. 389:1741–1755. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bader JE, Enos RT, Velázquez KT, Carson
MS, Nagarkatti M, Nagarkatti PS, Chatzistamou I, Davis JM, Carson
JA, Robinson CM, et al: Macrophage depletion using clodronate
liposomes decreases tumorigenesis and alters gut microbiota in the
AOM/DSS mouse model of colon cancer. Am J Physiol Gastrointest
Liver Physiol. 314:G22–G31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y,
Zhang T, Khaliq J and Li Y: miR-140-5p suppresses the
proliferation, migration and invasion of gastric cancer by
regulating YES1. Mol Cancer. 16:1392017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen J, Zhang S, Li Y, Zhang W, Chen J,
Zhang M, Wang T, Jiang L, Zou X, et al: p14ARF inhibits the
functions of adenovirus E1A oncoprotein. Biochem J. 434:275–285.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vinson KE, George DC, Fender AW, Bertrand
FE and Sigounas G: The Notch pathway in colorectal cancer. Int J
Cancer. 138:1835–1842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li G, Zhou Z, Zhou H, Zhao L, Chen D, Chen
H, Zou H, Qi Y, Jia W and Pang L: The expression profile and
clinicopathological significance of Notch1 in patients with
colorectal cancer: A meta-analysis. Future Oncol. 13:2103–2118.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamy M, Ferreira A, Dias JS, Braga S,
Silva G and Barbas A: Notch-out for breast cancer therapies. N
Biotechnol. 39:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mercey O, Popa A, Cavard A, Paquet A,
Chevalier B, Pons N, Magnone V, Zangari J, Brest P, Zaragosi LE, et
al: Characterizing isomiR variants within the microRNA-34/449
family. FEBS Lett. 591:693–705. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LG, Ni Y, Su BH, Mu XR, Shen HC and
Du JJ: MicroRNA-34b functions as a tumor suppressor and acts as a
nodal point in the feedback loop with Met. Int J Oncol. 42:957–962.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang L and Hermeking H: miR-34a and
miR-34b/c suppress intestinal tumorigenesis. Cancer Res.
77:2746–2758. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wallace KL, Zheng LB, Kanazawa Y and Shih
DQ: Immunopathology of inflammatory bowel disease. World J
Gastroenterol. 20:6–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peyrin-Biroulet L, Panés J, Sandborn WJ,
Vermeire S, Danese S, Feagan BG, Colombel JF, Hanauer SB and
Rycroft B: Defining disease severity in inflammatory bowel
diseases: Current and future directions. Clin Gastroenterol
Hepatol. 14:348–354.e7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hata K, Kishikawa J, Anzai H, Shinagawa T,
Kazama S, Ishii H, Nozawa H, Kawai K, Kiyomatsu T, Tanaka J, et al:
Surveillance colonoscopy for colitis-associated dysplasia and
cancer in ulcerative colitis patients. Dig Endosc. 28:260–265.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feuerstein JD and Cheifetz AS: Ulcerative
colitis: Epidemiology, diagnosis, and management. Mayo Clinic Proc.
89:1553–1563. 2014. View Article : Google Scholar
|
|
35
|
Bressenot A, Cahn V, Danese S and
Peyrin-Biroulet L: Microscopic features of colorectal neoplasia in
inflammatory bowel diseases. World J Gastroenterol. 20:3164–3172.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen R, Lai LA, Brentnall TA and Pan S:
Biomarkers for colitis-associated colorectal cancer. World J
Gastroenterol. 22:7882–7891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
de Santa Barbara P, van den Brink GR and
Roberts DJ: Development and differentiation of the intestinal
epithelium. Cell Mol Life Sci. 60:1322–1332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fazio C and Ricciardiello L: Inflammation
and Notch signaling: A crosstalk with opposite effects on
tumorigenesis. Cell Death Dis. 7:e25152016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takebe N, Nguyen D and Yang SX: Targeting
notch signaling pathway in cancer: Clinical development advances
and challenges. Pharmacol Ther. 141:140–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chu D, Zhang Z, Zhou Y, Wang W, Li Y,
Zhang H, Dong G, Zhao Q and Ji G: Notch1 and Notch2 have opposite
prognostic effects on patients with colorectal cancer. Ann Oncol.
22:2440–2447. 2011. View Article : Google Scholar : PubMed/NCBI
|
